A genetically engineered human Kunitz protease inhibitor with increased kallikrein inhibition in an ovine model of cardiopulmonary bypass

Ohri, S.K.; Parratt, R.; White, T.; Becket, J.; Brannan, J.J.; Hunt, B.J.; Taylor, K.M.
May 2001
Perfusion;May2001, Vol. 16 Issue 3, p199
Academic Journal
A recombinant human serine protease inhibitor known as Kunitz protease inhibitor (KPI) wild type has functional similarities to the bovine Kunitz inhibitor, aprotinin, and had shown a potential to reduce bleeding in an ovine model of cardiopulmonary bypass (CPB). The aim of this study was to assess KPI-185, a modification of KPI-wild type that differs from KPI-wild type in two amino acid residues and which enhances anti-kallikrein activity in a further double-blind, randomized study in an ovine model of CPB, and to compare with our previous study of KPI-wild type and aprotinin in the same ovine model. Post-operative drain losses and subjective assessment of wound 'dryness' showed no significant differences between KPI-185 and KPI-wild type, despite the significant enhancement of kallikrein inhibition using KPI-185 seen in serial kallikrein inhibition assays. These preliminary findings support the hypothesis that kallikrein inhibition is not the major mechanism by which Kunitz inhibitors such as aprotinin reduce perioperative bleeding.


Related Articles

  • aprotinin.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p169 

    An encyclopedia entry for "aprotinin," which pertains to a serine protease inhibitor derived from bovine pancreas and is used to decrease blood loss preventing transfusion during surgery, is presented.

  • Design of potent selective zinc-mediated serine protease inhibitors. Katz, Bradley A.; Clark, James M.; Finer-Moore, Janet S.; Jenkins, Thomas E.; Johnson, Charles R.; Ross, Michael J.; Luong, Christine; Moore, William R.; Stroud, Robert M. // Nature;2/5/1998, Vol. 391 Issue 6667, p608 

    Reports a mode of high-affinity binding in which a zinc2+ ion is tetrahedrally coordinated between two chelating nitrogens of BABIM and two active site residues, His 57 and Ser 195. What is implied by the distinct Zn2+ coordination geometry; The suggestion that small molecule inhibitors of...

  • SPINK1 variants in young-onset pancreatic cancer. Hucl, Tomas; Jesnowski, Ralf; Pfützer, Roland H.; Elsässer, Hans-Peter; Löhr, Matthias // Journal of Gastroenterology;Jul2007, Vol. 42 Issue 7, p599 

    A letter to the editor is presented about the differential roles of the serine protease inhibitor Kazal type 1 (SPINK1) gene alterations in patients with alcoholic and nonalcholic chronic pancreatitis, that was published in a previous issue.

  • De-mystifying the mechanism(s) of maspin. Hendrix, Mary J.C. // Nature Medicine;Apr2000, Vol. 6 Issue 4, p374 

    Discusses Z. Zhang and colleagues' research that provides evidence that maspin or mammary serine protease inhibitor is also an effective inhibitor of angiogenesis. Effect of maspin expression on neovascularization; Role of maspin in inducing apoptosis of endothelial cells through specific...

  • 1.45 Ã… resolution structure of SRPN18 from the malaria vector Anopheles gambiae. Meekins, David A.; Zhang, Xin; Battaile, Kevin P.; Lovell, Scott; Michel, Kristin // Acta Crystallographica: Section F, Structural Biology Communicat;Dec2016, Vol. 72 Issue 12, p853 

    Serine protease inhibitors (serpins) in insects function within development, wound healing and immunity. The genome of the African malaria vector, Anopheles gambiae, encodes 23 distinct serpin proteins, several of which are implicated in disease-relevant physiological responses. A. gambiae...

  • Coagulation Factor Xa Inhibition: Biological Background and Rationale. Leadley Jr., Robert J. // Current Topics in Medicinal Chemistry;Jun2001, Vol. 1 Issue 2, p151 

    Ischemic heart disease and cerebrovascular disease are the leading causes of death in the world. Surprisingly, these diseases are treated by relatively antiquated drugs. However, due to our improved understanding of the underlying pathology of these diseases, and a number of technological...

  • Clinic Roundup.  // BioWorld Today;10/ 8/2012, Vol. 23 Issue 195, p9 

    This section offers news briefs on clinical trials, including the voluntary discontinuation by the Medicines Co. of its Phase IIb dose-ranging study of MDCO-2010, a serine protease inhibitor being developed for the reduction of blood loss during surgery.

  • Maspin sensitizes breast carcinoma cells to induced apoptosis. Ning Jiang; Yonghong Meng; Suliang Zhang; Mensah-Osman, Edith; Shijie Sheng // Oncogene;6/13/2002, Vol. 21 Issue 26, p4089 

    Presents a study that examined the effect of maspin, an endogenous mammary serine protease inhibitor, in mammary carcinoma cells on staurosporine-induced apoptosis. Background on serpins included in maspin; Functions of maspin; Impact of maspin transgene expression on the mouse mammary gland;...

  • Human genetics and disease: Serpinopathies and the conformational dementias. Lomas, David A.; Carrell, Robin W. // Nature Reviews Genetics;Oct2002, Vol. 3 Issue 10, p759 

    The serpin superfamily of serine proteinase inhibitors has a central role in controlling proteinases in many biological pathways in a wide range of species. The inhibitory function of the serpins involves a marked conformational transition, but this inherent molecular flexibility also renders...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics